z-logo
open-access-imgOpen Access
Consolidation therapy is necessary following successful biofeedback treatment for pubertal chronic prostatitis patients: A 3-year follow-up study
Author(s) -
Jun Wang,
Lin Qi,
Xiang Yang Zhang,
Yuan Dai,
Yuan Li
Publication year - 2013
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/0300060513477582
Subject(s) - medicine , biofeedback , prostatitis , urination , physical therapy , residual volume , urinary system , prostate , cancer , lung volumes , lung
Objective To assess long-term effects of biofeedback training on pubertal chronic prostatitis (CP).Methods Pubertal CP patients received 12-week intensive biofeedback training and were divided into two groups: group 1 received further monthly training ≥24 (26–36) months; group 2 received further monthly training <24 (13–23) months. National Institutes of Health–CP Symptom Index (NIH–CPSI) scores, maximum urinary flow rate (Q max ) and postvoid residual urine volume (PVR) were recorded monthly.Results Total NIH–CPSI scores decreased significantly in group 1 ( n = 10; mean age ± SD 16.5 ± 1.1 years) together with all subdomain scores (pain, urination, life impact). Total NIH–CPSI scores increased significantly in group 2 ( n = 12; mean age ± SD 16.3 ± 1.2 years) at 30 and 36 months, and were significantly different from group 1 at these time points. Urination and life-impact scores increased significantly and Q max decreased significantly in group 2 at 30 and 36 months. PVR was unchanged in either group.Conclusions Twelve-week intensive biofeedback training requires lengthy consolidation sessions to achieve long-term success. Further investigation should assess longer intervals between consolidation sessions, for improving patient compliance and outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here